期刊
JOURNAL OF PEDIATRIC SURGERY
卷 44, 期 2, 页码 377-380出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.jpedsurg.2008.10.088
关键词
Multidrug resistance; MDR1; MRP1; LRP; Pediatric malignancy
Background/Purpose: The overexpression of multidrug resistance (MDR) associated genes in primary untreated tumors has been proven to be associated with worse prognosis in various pediatric malignancies. This Study compared the expression of 3 MDR-associated genes, MDR1, MDR-associated protein 1 (MRP1), and lung resistance related protein (LRP), in pediatric tumors before and after chemotherapy to elucidate the mechanism of MDR during chemotherapy. Methods: Surgical specimens of both primary and chemotherapy-treated tumors were obtained from 24 patients with pediatric malignancies (neuroblastoma [NB] 8; hepatoblastoma [HB] 8; Wilms tumor [WT] 4; rhabdomyosarcoma [RB] 4). The expression of MDR1, MRP1, and LRP was evaluated using the immunohistochemical staining. Results: In primary tumors, MDR1 expression was observed in 6 NBs, 9 HBs, 3 WTs, and 3 RBs. MRP1 expression was observed in 3 NBs and I HB. LRP expression was not detected in,my of the primary tumors. After chemotherapy, MDR1 expression was observed to increase in 5 NBs, 4 HBs, 2 WTs, and 3 RBs. MRP1 expression was newly observed or increased in 7 NBs, 4 HBs, and 3 RBs. LRP expression was newly observed in 3 HBs and 2 WTs. Conclusions: These results indicate that these 3 MDR-associated genes were upregulated after chemotherapy in various pediatric malignancies. These findings may be useful to Understand the mechanism of drug resistance in pediatric malignancies. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据